Nutrition in pediatric inflammatory bowel disease

Nutrition in Clinical Practice

Volumn 25, Issue 4, 2010, Pages 335-339

  Mallon, Daniel P ^a   Suskind, David L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

avitaminosis; colitis; Crohng's disease; deficiency diseases; enteral nutrition; inflammatory bowel diseases; nutrition disorders; nutrition therapy; parenteral nutrition; pediatrics; ulcerative

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CYANOCOBALAMIN; FERROUS FUMARATE; FERROUS SULFATE; FISH OIL; FOLIC ACID; IRON; METHOTREXATE; OMEGA 3 FATTY ACID; RETINOL; SALAZOSULFAPYRIDINE; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D; VITAMIN K GROUP;

ALPHA TOCOPHEROL DEFICIENCY; CALCIUM DEFICIENCY; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DIET THERAPY; DISEASE ASSOCIATION; ENTERIC FEEDING; ENTERITIS; FOLIC ACID DEFICIENCY; GROWTH DISORDER; HUMAN; HYPERHOMOCYSTEINEMIA; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; LACTOSE INTOLERANCE; MACROCYTIC ANEMIA; MACRONUTRIENT; MALNUTRITION; OSTEOPENIA; OSTEOPOROSIS; PARENTERAL NUTRITION; REVIEW; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

CHILD; HUMANS; INFLAMMATORY BOWEL DISEASES; MALNUTRITION; MICRONUTRIENTS; NUTRITIONAL SUPPORT;

EID: 78649270345     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533610373773     Document Type: Review

References (57)

1. Oliva MM, Lake AM Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition. 1996 ; 12: 151-158.
2. Motil KJ, Grand RJ, Davis-Kraft L., Ferlic LL, Smith EO Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993 ; 105: 681-691.
3. Rosenthal SR, Snyder JD, Hendricks KM, Walker WA Growth failure and inflammatory bowel disease: approach to treatment of a complicated adolescent problem. Pediatrics. 1983 ; 72: 481-490.
4. Kanof ME, Lake AM, Bayless TM Decreased height velocity in children and adolescents before the diagnosis of Crohng's disease. Gastroenterology. 1988 ; 95: 1523-1527.
5. Markowitz J., Grancher K., Rosa J., Aiges H., Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993 ; 16: 373-380.
6. Castile RG, Telander RL, Cooney DR, et al. Crohng's disease in children: assessment of the progression of disease, growth, and prognosis. J Pediatr Surg. 1980 ; 15: 462-469.
7. Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS Growth, body composition, and nutritional status in children and adolescents with Crohng's disease. J Pediatr Gastroenterol Nutr. 2000 ; 31: 33-40.
8. Hildebrand H., Karlberg J., Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994 ; 18: 165-173. (Pubitemid 24056474)
9. Hartman C., Eliakim R., Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009 ; 15: 2570-2578.
10. Kleinman RE, Baldassano RN, Caplan A., et al. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology And Nutrition. J Pediatr Gastroenterol Nutr. 2004 ; 39: 15-27.
11. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 1997 ; 65: 564-567.
12. Gokhale R., Favus MJ, Karrison T., Sutton MM, Rich B., Kirschner BS Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology. 1998 ; 114: 902-911.
13. Lopes LH, Sdepanian VL, Szejnfeld VL, de Morais MB, Fagundes-Neto U. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease. Dig Dis Sci. 2008 ; 53: 2746-2753.
14. Sentongo TA, Semaeo EJ, Stettler N., Piccoli DA, Stallings VA, Zemel BS Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002 ; 76: 1077-1081.
15. Pappa HM, Grand RJ, Gordon CM Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006 ; 12: 1162-1174.
16. Issenman RM, Atkinson SA, Radoja C., Fraher L. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohng's disease. J Pediatr Gastroenterol Nutr. 1993 ; 17: 401-406.
17. Bousvaros A., Zurakowski D., Duggan C., et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998 ; 26: 129-135.
18. Schoon EJ, Muller MC, Vermeer C., Schurgers LJ, Brummer RJ, Stockbrugger RW Low serum and bone vitamin K status in patients with longstanding Crohng's disease: another pathogenetic factor of osteoporosis in Crohng's disease ? Gut. 2001 ; 48: 473-477.
19. Kuwabara A., Tanaka K., Tsugawa N., et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int. 2009 ; 20: 935-942.
20. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohng's disease. Aliment Pharmacol Ther. 2006 ; 24: 1507-1523.
21. Revel-Vilk S., Tamary H., Broide E., et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur J Pediatr. 2000 ; 159: 585-589.
22. Erichsen K., Ulvik RJ, Nysaeter G., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol. 2005 ; 40: 1058-1065.
23. de Silva AD, Tsironi E., Feakins RM, Rampton DS Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther. 2005 ; 22: 1097-1105.
24. Schroder O., Mickisch O., Seidler U., et al. Intravenous iron sucrose vs oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005 ; 100: 2503-2509.
25. Harvey RS, Reffitt DM, Doig LA, et al. Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of iron. Aliment Pharmacol Ther. 1998 ; 12: 845-848.
26. Nakano E., Taylor CJ, Chada L., McGaw J., Powers HJ Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2003 ; 37: 586-590.
27. Heyman MB, Garnett EA, Shaikh N., Jose FA, Harmatz P., Winter HS, Baldassano RN, Cohen SA, Gold BD, Kirschner BS, Ferry GD, Stege E., Holland N. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease. Am J Clin Nutr. 2009 ; 89: 545-550.
28. Phelip JM, Ducros V., Faucheron JL, Flourie B., Roblin X. Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008 ; 14: 242-248.
29. Bjerregaard LT, Nederby NJ, Fredholm L., Brandslund I., Munkholm P., Hey H. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002 ; 37: 62-67.
30. Belli DC, Seidman E., Bouthillier L., et al. Chronic intermittent elemental diet improves growth failure in children with Crohng's disease. Gastroenterology. 1988 ; 94: 603-610.
31. Polk DB, Hattner JA, Kerner JA Jr. Improved growth and disease activity after intermittent administration of a defined formula diet in children with Crohng's disease. JPEN J Parenter Enteral Nutr. 1992 ; 16: 499-504.
32. Kleinman RE, Balistreri WF, Heyman MB, et al. Nutritional support for pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1989 ; 8: 8-12.
33. Gerasimidis K., McGrogan P., Hassan K., Edwards CA Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2008 ; 27: 155-165.
34. Sakamoto N., Kono S., Wakai K., et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005 ; 11: 154-163.
35. Ritchie JK, Wadsworth J., Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohng's disease. Br Med J (Clin Res Ed). 1987 ; 295: 517-520.
36. Levenstein S., Prantera C., Luzi C., Dg'Ubaldi A. Low residue or normal diet in Crohng's disease: a prospective controlled study in Italian patients. Gut. 1985 ; 26: 989-993.
37. Brandes JW, Lorenz-Meyer H. Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Z Gastroenterol. 1981 ; 19: 1-12.
38. Mishkin B., Yalovsky M., Mishkin S. Increased prevalence of lactose malabsorption in Crohng's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997 ; 92: 1148-1153.
39. Lorenz-Meyer H., Bauer P., Nicolay C., et al. ω-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohng's disease: a randomized controlled multicenter trial. Study Group Members (German Crohng's Disease Study Group). Scand J Gastroenterol. 1996 ; 31: 778-785.
40. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohng's disease. N Engl J Med. 1996 ; 334: 1557-1560.
41. Aslan A., Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol. 1992 ; 87: 432-437.
42. Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut. 1992 ; 33: 922-928.
43. Stenson WF, Cort D., Rodgers J., et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med. 1992 ; 116: 609-614.
44. Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993 ; 7: 159-166.
45. Mullen JL, Hargrove WC, Dudrick SJ, Fitts WT Jr, Rosato EF Ten years experience with intravenous hyperalimentation and inflammatory bowel disease. Ann Surg. 1978 ; 187: 523-529.
46. Scolapio JS The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease. J Clin Gastroenterol. 1999 ; 29: 223-224.
47. Strobel CT, Byrne WJ, Ament ME Home parenteral nutrition in children with Crohng's disease: an effective management alternative. Gastroenterology. 1979 ; 77: 272-279.
48. Day AS, Whitten KE, Lemberg DA, et al. Exclusive enteral feeding as primary therapy for Crohng's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol. 2006 ; 21: 1609-1614.
49. Hartman C., Berkowitz D., Weiss B., et al. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohng's disease. Isr Med Assoc J. 2008 ; 10: 503-507.
50. Heuschkel RB, Menache CC, Megerian JT, Baird AE Enteral nutrition and corticosteroids in the treatment of acute Crohng's disease in children. J Pediatr Gastroenterol Nutr. 2000 ; 31: 8-15.
51. Johnson T., Macdonald S., Hill SM, Thomas A., Murphy MS Treatment of active Crohng's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006 ; 55: 356-361.
52. Dziechciarz P., Horvath A., Shamir R., Szajewska H. Meta-analysis: enteral nutrition in active Crohng's disease in children. Aliment Pharmacol Ther. 2007 ; 26: 795-806.
53. Afzal NA, Davies S., Paintin M., et al. Colonic Crohng's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci. 2005 ; 50: 1471-1475.
54. Knight C., El- Matary W., Spray C., Sandhu BK Long-term outcome of nutritional therapy in paediatric Crohng's disease. Clin Nutr. 2005 ; 24: 775-779.
55. Ludvigsson JF, Krantz M., Bodin L., Stenhammar L., Lindquist B. Elemental vs polymeric enteral nutrition in paediatric Crohng's disease: a multicentre randomized controlled trial. Acta Paediatr. 2004 ; 93: 327-335.
56. Fell JM Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr. 2005 ; 29 (4 Suppl). S126-8 ; discussion S9-S33, S84 - S88.
57. Akobeng AK, Miller V., Stanton J., Elbadri AM, Thomas AG Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohng's disease. J Pediatr Gastroenterol Nutr. 2000 ; 30: 78-84.